Department of Pharmacy Practice

Diane M. Cappelletty, Pharm.D.

Photo of Dr. Cappelletty

Associate Professor of Clinical Pharmacy
Vice Chair
Department of Pharmacy Practice

Co-Director, The Infectious Disease Research Laboratory

419.383.1957
Frederic and Mary Wolfe Center 114C
dcappel@utnet.utoledo.edu

Education

  • Doctor of Pharmacy Program, the Ohio State University College of Pharmacy
  • Bachelor of Science in Pharmacy, the Ohio State University College of Pharmacy
  • Medical Technology ASCP Certified, Mercy Hospital
  • Bachelor of Arts in Biology, The University of Toledo

Scope of Practice and Curriculum

Infectious Disease

Professional Experience

Associate Professor of Pharmacy Practice, The University of Toledo College of Pharmacy and Pharmaceutical Sciences

Recent Publications

Book Chapters

  1. Cappelletty DM. Respiratory Infections. Pharmacotherapy Principles and Practice 2nd Edition. 2009 McGraw Hill.
  2. Cappelletty DM. Agents with Gram-Positive Activity. Textbook of Critical Care 6th Edition. 2010 Elsevier Saunders.
  3. Cappelletty DM. Pneumonia Case. Pharmacotherapy Principles and Practice Study Guide A Case-Based Care Plan Approach. 2010 McGraw Hill.
  4. Cappelletty DM. Respiratory Infections. Pharmacotherapy Principles and Practice 3rdEdition. 2013 McGraw Hill.
  5. Cappelletty DM. Pneumonia Case. Pharmacotherapy Principles and Practice Study Guide A Case-Based Care Plan Approach 2nd
  6. Cappelletty DM, Jacobs DM, Klochan SA. Pneumonia Case. Pharmacotherapy Principles and Practice Study Guide A Case-Based Care Plan Approach 3rd Edition, McGraw Hill.

Abstracts

  1. Shiner C, Cappelletty DM. A Comparison of Vancomycin to Metronidazole for the Treatment of Clostridium difficile. Resident Poster Presentation 43rd Clinical Meeting, American Society of Health-System Pharmacists. December 2009.
  2. Yost R, Cappelletty DM. Retrospective Cohort of Extended-Infusion Piperacillin/Tazobactam(RECEIPT): A Multicenter Study. Resident Poster Presentation 43nd Midyear Clinical Meeting, American Society of Health-System Pharmacists. December 2009.
  3. Cammarata D, Cappelletty DM. Outcomes of Urinary Tract Infections Due to Candida Species in Patients with Varying Degrees of Renal Function. Resident Poster Presentation 44th Annual Midyear Clinical Meeting, American Society of Health-System Pharmacists. December 2010.
  4. Rivera C, Cappelletty DM. Impact of Antimicrobial Prophylaxis on Infection Rates Post Total Hip and Knee Arthroplasty. Resident Poster Presentation 44th Clinical Meeting, American Society of Health-System Pharmacists. December 2010.
  5. Leis R, Cappelletty DM. Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus respiratory tract infections in the critically ill. Resident Poster Presentation 44th Pharmacists. December 2010.
  6. Jacobs D, Cappelletty DM. Outcomes from pharmacist’s interventions in an antimicrobial stewardship program. Resident Poster Presentation 45th Clinical Meeting, American Society of Health-System Pharmacists. December 2011.
  7. Klochan S, Williams M, Cappelletty DM. Effect of an antimicrobial stewardship pilot program on the acceptance of antimicrobial recommendations in a surgical intensive care unit (SICU). Resident Poster Presentation 45th American Society of Health-System Pharmacists. December 2011.
  8. Kolehmainen N, Cappelletty DM, Mullin J. Interdisciplinary Team Approach to Improve Compliance of Pneumonia Core Measures. Resident Poster Presentation 46th Annual Midyear Clinical Meeting, American Society of Health-System Pharmacists. December 2012.
  9. Austin J, Pontefact B, Cappelletty DM. Risk Factors Associated with Readmission Following Initial Hospitalization for Pneumonia. Resident Poster Presentation 47th Annual Midyear Clinical Meeting, American Society of Health-System Pharmacists. December 2013.

Peer-Reviewed Articles

  1. Powers MF, Cappellety DM, Shimman JJ, Kaun MA, Capurs KA. A practical approach for training pharmacists and pharmacy students to prevent diseases by immunizations. Journal of Pharmacy Practice online www.jpp.sagepub.com January 2009.
  2. Cappelletty DM, Jung R. Anidulafungin and its Role in Candida Infections. Infection and Drug Resistance 2009:2 51–60.
  3. Peeters MJ, Churchwell MD, Mauro LS, Cappelletty DM, Stone GE. A student inclusive pharmacotherapeutics textbook selection process. Currents in Pharmacy Teaching & Learning 2010:2 31-38.
  4. Yost R, Cappelletty DM. Retrospective Cohort of Extended-Infusion Piperacillin/Tazobactam(RECEIPT): A Multicenter Study. Pharmacotherapy
  5. 2011;31(8):767-775. Annual Midyear Clinical Meeting, American Society of Health-System
  6. Jacobs D, Cappelletty DM. Evaluating the impact of a pharmacist’s absence from an antimicrobial stewardship team. Am J Health-Syst Pharm 2013;Vol 70 Jun 15:1065-1069.
  7. Cappelletty DM, Jablonski A, Jung R. Risk factors for acute kidney injury in adult patients receiving Vancomycin. Clin Drug Invest 2014;34(3):189-193.

Recent Awards

  • Outstanding Teacher of the Year Award
  • Outstanding Professor of the Year Award
  • Humanitarian Award, The Ohio Society of Health-System Pharmacists, 2013
  • Shining Star Award, The University of Toledo, 2014

Leadership 

  • Co-Chair; College of Pharmacy Curriculum Committee
  • Treasurer; Toledo Area Society of Health-System Pharmacists
Last Updated: 3/22/15